1. ALLA AKTIER
  2. NYHETER
  3. SANIONA

Saniona

Nyheter Saniona Nyheter alla bolag
Hej Visste du att du med vår premiumtjänst får fullständig historik i alla grafer, pressmeddelanden och andra notiser för dina favoritbolag direkt som DM i Discord samt en del andra godsaker? Du slipper dessutom störande annonser på sajten. Testa gratis i 14 dagar!

Invitation to Saniona Q2 investor call on 27 August 2026

Saniona (OMX: SANION), a clinical-stage biopharmaceutical company, will host a Q2 investor call on 27 August 2026, at 11.00 CEST.

At the call Management will be presenting results and a company update. At the end of the presentation there will be a Q&A session, where participants can ask online questions.

Access to the event can be obtained through the following link:

Live Q: Saniona - Redeye

REPLAY access
Webcast replay will be available at www.saniona.com and at www.redeye.se

For more information, please contact
Johnny Stilou, CFO, +45 21227227; johnny.stilou@saniona.com

About Saniona
Saniona is a clinical-stage biopharmaceutical company focused on discovering, developing, and delivering innovative treatments for neurological and psychiatric disorders. The company’s internal pipeline includes SAN2668 for pediatric epilepsy syndromes, SAN2219 for epilepsy, and SAN2465 for major depressive disorder. Saniona has established strategic collaborations with leading pharmaceutical companies, including Jazz Pharmaceuticals, which holds global rights to SAN2355 for epilepsy, Acadia Pharmaceuticals, which holds worldwide rights to ACP-711 for essential tremor, and with Medix, which holds rights to tesofensine for obesity in Mexico and Argentina. Saniona’s ion channel discovery platform is further validated through research collaborations with Boehringer Ingelheim, Cephagenix, and AstronauTx, which holds worldwide rights to ATX0926. Headquartered in Copenhagen, Saniona is listed on the Nasdaq Stockholm Main Market.

For more information, visit www.saniona.com.

Attachments
Invitation to Saniona Q2 investor call on 27 August 2026

Datum 2026-08-20, kl 08:00
Källa MFN
Bifogade filer
Invitation to Saniona Q2 investor call on 27 August 2026